{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:21:06Z","timestamp":1783066866596,"version":"3.54.6"},"reference-count":26,"publisher":"Galenos Yayinevi","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Phys Med Rehab"],"accepted":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    This study aims to evaluate the influence of complex decongestive therapy (CDT) on patients with breast cancer-related lymphedema (BCRL) in terms of reducing volume, improving functional capabilities, and enhancing the quality of life and analyze the effect of obesity on their recovery process.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Patients and methods:<\/jats:bold>\n                    This retrospective study was conducted between January 2018 and March 2020. The investigation comprised individuals with unilateral BCRL who received CDT during the previous year. The participants were split into two classifications: those with a normal or overweight status (Group 1) and those classified as obese or morbidly obese (Group 2). Each participant engaged in CDT sessions five times weekly for three weeks. The groups were compared regarding their functional status and quality of life scores as measured by the Quick Disabilities of the Arm, Shoulder, and Hand and Lymphedema Quality of Life (LYMQOL)-Arm questionnaires.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    This study included 81 female patients (mean age: 53.6\u00b110.4 years; range, 28 to 87 years) with BCRL. Half of the participants were identified as obese and the mean body mass index (BMI) was 30.32\u00b14.63 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    . The median lymphedema duration was 12 months. After treatment, there was a notable reduction in both the mean initial limb volume and excess volumes (3183\u00b1681 cm\n                    <jats:sup>3<\/jats:sup>\n                    <jats:italic>vs.<\/jats:italic>\n                    2912\u00b1599 cm\n                    <jats:sup>3<\/jats:sup>\n                    and 30.1%\n                    <jats:italic>vs.<\/jats:italic>\n                    19.3%, respectively; p&lt;0.001). Both groups showed substantial and similar enhancements in volumes, functional scores, and all subscores of the LYMQOL-Arm questionnaire following CDT. When the patients with a BMI below and above 30 were compared, the improvement in function and appearance scores of LYMQOL-Arm was substantially distinct between the two categories. We also indicated a substantial negative relationship between the enhancement of LYMQOL-Arm function and appearance subscores and BMI (p=0.005, r=\u20130.486 and p=0.042, r=\u20130.361).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The influence of CDT on decreasing volume and improving functionality was comparable between obese and nonobese patients with BCRL; however, obesity may negatively impact CDT outcomes concerning quality of life issues.\n                  <\/jats:p>","DOI":"10.5606\/tftrd.2025.15576","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T01:36:02Z","timestamp":1746754562000},"page":"48-55","source":"Crossref","is-referenced-by-count":2,"title":["The impact of obesity on the outcomes of complex decongestive therapy among patients with breast cancer-related lymphedema"],"prefix":"10.4274","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8097-4208","authenticated-orcid":false,"given":"Aysegul","family":"Yaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-6797","authenticated-orcid":false,"given":"P\u0131nar","family":"Borman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3081-5465","authenticated-orcid":false,"given":"Funda","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Tandra P, Kallam A, Krishnamurthy J. Identification and management of lymphedema in patients with breast cancer. J Oncol Pract 2019;15:255-62. doi: 10.1200\/JOP.18.00141.","DOI":"10.1200\/JOP.18.00141"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Zuther JE, Norton S. Pathology. In: Zuther JE, Norton S, editors. Lymphedema management: The comprehensive guide for practitioners. 3rd ed. Sttuttgard: Thieme Verlag; 2013. p. 45-126.","DOI":"10.1055\/b-0034-91077"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Liao SF, Li SH, Huang HY, Chen ST, Kuo SJ, Chen DR, et al. The efficacy of Complex Decongestive Physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in Breast Cancer-Related Lymphedema (BCRL). Breast 2013;22:703-6. doi: 10.1016\/j. breast.2012.12.018.","DOI":"10.1016\/j.breast.2012.12.018"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Michelotti A, Invernizzi M, Lopez G, Lorenzini D, Nesa F, De Sire A, et al. Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical management. Breast 2019;44:15-23. doi: 10.1016\/j.breast.2018.12.009.","DOI":"10.1016\/j.breast.2018.12.009"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Anbari AB, Wanchai A, Armer JM. Breast cancer-related lymphedema and quality of life: A qualitative analysis over years of survivorship. Chronic Illn 2021;17:257-68. doi: 10.1177\/1742395319872796.","DOI":"10.1177\/1742395319872796"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Mehrara BJ, Greene AK. Lymphedema and obesity: Is there a link? Plast Reconstr Surg 2014;134:154e-60. doi: 10.1097\/ PRS.0000000000000268.","DOI":"10.1097\/PRS.0000000000000268"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Ugur S, Ar\u0131c\u0131 C, Yaprak M, Mesc\u0131 A, Ar\u0131c\u0131 GA, Dolay K, et al. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol 2013;11:72-5. doi: 10.1089\/lrb.2013.0004.","DOI":"10.1089\/lrb.2013.0004"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2010;16:48- 54. doi: 10.1111\/j.1524-4741.2009.00855.x.","DOI":"10.1111\/j.1524-4741.2009.00855.x"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Duyur Cak\u0131t B, Pervane Vural S, Ayhan FF. Complex decongestive therapy in breast cancer-related lymphedema: Does obesity affect the outcome negatively? Lymphat Res Biol 2019;17:45-50. doi: 10.1089\/lrb.2017.0086.","DOI":"10.1089\/lrb.2017.0086"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol 2013;14:500-15. doi: 10.1016\/S1470-2045(13)70076-7.","DOI":"10.1016\/S1470-2045(13)70076-7"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Roberts SA, Gillespie TC, Shui AM, Brunelle CL, Daniell KM, Locascio JJ, et al. Weight loss does not decrease risk of breast cancer-related arm lymphedema. Cancer 2021;127:3939-45. doi: 10.1002\/cncr.33819.","DOI":"10.1002\/cncr.33819"},{"key":"ref-12","unstructured":"He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett 2020;19:2085-96. doi: 10.3892\/ ol.2020.11307."},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Boyages J, Cave AE, Naidoo D, Ee CCL. Weight gain and lymphedema after breast cancer treatment: Avoiding the catch-22? Lymphat Res Biol 2022;20:409-16. doi: 10.1089\/ lrb.2020.0048.","DOI":"10.1089\/lrb.2020.0048"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Objective measurements. J Clin Oncol 2008;26:5213-9. doi: 10.1200\/JCO.2008.16.3725.","DOI":"10.1200\/JCO.2008.16.3725"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Ridner SH, Dietrich MS, Stewart BR, Armer JM. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011;19:853-7. doi: 10.1007\/s00520- 011-1089-9.","DOI":"10.1007\/s00520-011-1089-9"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Arngrim N, Simonsen L, Holst JJ, B\u00fclow J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: A possible link between obesity and local tissue inflammation? Int J Obes (Lond) 2013;37:748-50. doi: 10.1038\/ijo.2012.98.","DOI":"10.1038\/ijo.2012.98"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Greene AK, Zurakowski D, Goss JA. Body mass index and lymphedema morbidity: Comparison of obese versus normal-weight patients. Plast Reconstr Surg 2020;146:402-7. doi: 10.1097\/PRS.0000000000007021.","DOI":"10.1097\/PRS.0000000000007021"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PMR 2012;4:580-601. doi: 10.1016\/j.pmrj.2012.05.003.","DOI":"10.1016\/j.pmrj.2012.05.003"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Torgbenu E, Luckett T, Buhagiar MA, Phillips JL. Guidelines relevant to diagnosis, assessment, and management of lymphedema: A systematic review. Adv Wound Care (New Rochelle) 2023;12:15-27. doi: 10.1089\/wound.2021.0149.","DOI":"10.1089\/wound.2021.0149"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Eyig\u00f6r S, Cinar E, Caramat I, Unlu BK. Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema. Support Care Cancer 2015;23:2705-10. doi: 10.1007\/s00520-015-2633-9.","DOI":"10.1007\/s00520-015-2633-9"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"Vignes S, Porcher R, Champagne A, Dupuy A. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: A cohort study. Breast Cancer Res Treat 2006;98:1-6. doi: 10.1007\/s10549-005-9021-y.","DOI":"10.1007\/s10549-005-9021-y"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Koldas Dogan S, Ay S, Evcik D, Baser O. Adaptation of Turkish version of the questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in patients with carpal tunnel syndrome. Clin Rheumatol 2011;30:185-91. doi: 10.1007\/s10067-010-1470-y.","DOI":"10.1007\/s10067-010-1470-y"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Borman P, Yaman A, Denizli M, Karahan S, \u00d6zdemir O. The reliability and validity of lymphedema quality of life questionnaire-arm in Turkish patients with upper limb lymphedema related with breast cancer. Turk J Phys Med Rehabil 2018;64:205-12. doi: 10.5606\/tftrd.2018.2843.","DOI":"10.5606\/tftrd.2018.2843"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Shamoun S, Ahmad M. Complete decongestive therapy effect on breast cancer related to lymphedema: A systemic review and meta-analysis of randomized controlled trials. Asian Pac J Cancer Prev 2023;24:2225-38. doi: 10.31557\/ APJCP.2023.24.7.2225.","DOI":"10.31557\/APJCP.2023.24.7.2225"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Donahue PMC, MacKenzie A, Filipovic A, Koelmeyer L. Advances in the prevention and treatment of breast cancerrelated lymphedema. Breast Cancer Res Treat 2023;200:1- 14. doi: 10.1007\/s10549-023-06947-7.","DOI":"10.1007\/s10549-023-06947-7"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Fish ML, Grover R, Schwarz GS. Quality-of-life outcomes in surgical vs nonsurgical treatment of breast cancerrelated lymphedema: A systematic review. JAMA Surg 2020;155:513-9. doi: 10.1001\/jamasurg.2020.0230.","DOI":"10.1001\/jamasurg.2020.0230"}],"container-title":["Turkish Journal of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:08:28Z","timestamp":1783066108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4580.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.5606\/tftrd.2025.15576","relation":{},"ISSN":["2587-1250"],"issn-type":[{"value":"2587-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}